A Critical Review of Clinical Arteriogenesis Research

Journal of the American College of Cardiology

Volumn 55, Issue 1, 2009, Pages 17-25

  van Royen, Niels ^a   Piek, Jan J ^a   Schaper, Wolfgang ^b   Fulton, William F ^c  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

angiogenesis; arteriogenesis; collateral circulation; genomics; intracoronary hemodynamics

Indexed keywords

FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR 4; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; PLACEBO; VASCULOTROPIN;

ADAPTATION; ANGIOGENESIS; ANGIOGRAPHY; AUTOPSY; BLOOD VESSEL WALL; CELL PROLIFERATION; COLLATERAL CIRCULATION; CORONARY ARTERY; CORONARY ARTERY COLLATERAL CIRCULATION; CORONARY ARTERY OBSTRUCTION; ENZYME DEGRADATION; EXPERIMENTAL STUDY; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HUMAN; ISCHEMIA; MONOCYTE; NONHUMAN; PRESSURE MEASUREMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REVIEW; SENSITIVITY ANALYSIS; SHEAR STRESS; STRUCTURE ANALYSIS; ULTRASTRUCTURE ANALYSIS AND ELECTRON MICROSCOPY;

ANIMALS; COLLATERAL CIRCULATION; CORONARY VESSELS; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC;

EID: 72549087208     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.06.058     Document Type: Review

References (58)

1. Fulton W.F.M. Chronic generalised myocardial ischaemia with advanced coronary artery disease. Br Heart J 18 (1956) 341-352
2. Zoll P.M., Wessler S., and Blumgart H.L. Angina pectoris: a clinical and pathological correlation. Am J Med 11 (1951) 331-339
3. Fulton W.F.M. The Coronary Arteries: Arteriography, Microanatomy and Pathogenesis of Obliterative Coronary Artery Disease (1965), Charles C. Thomas, Springfield, IL
4. Surmely J.F., Katoh O., Tsuchikane E., Nasu K., and Suzuki T. Coronary septal collaterals as an access for the retrograde approach in the percutaneous treatment of coronary chronic total occlusions. Catheter Cardiovasc Interv 69 (2007) 826-832
5. Fulton W.F.M. Arterial anastomoses in the coronary circulation. I. Anatomical features in normal and diseased hearts demonstrated by stereoarteriography. Scot Med J 8 (1963) 420-434
6. Fulton W.F.M. Anastomotic enlargement and ischaemic myocardial damage. Br Heart J 26 (1964) 1-15
7. Rentrop K.P., Cohen M., Blanke H., and Phillips R.A. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 5 (1985) 587-592
8. Williams D.O., Amsterdam E.A., Miller R.R., and Mason D.T. Functional significance of coronary collateral vessels in patients with acute myocardial infarction: relation to pump performance, cardiogenic shock and survival. Am J Cardiol 37 (1976) 345-351
9. Schwartz H., Leiboff R.H., Bren G.B., et al. Temporal evolution of the human coronary collateral circulation after myocardial infarction. J Am Coll Cardiol 4 (1984) 1088-1093
10. Werner G.S., Ferrari M., Heinke S., et al. Angiographic assessment of collateral connections in comparison with invasively determined collateral function in chronic coronary occlusions. Circulation 107 (2003) 1972-1977
11. Meier B., Luethy P., Finci L., Steffenino G.D., and Rutishauser W. Coronary wedge pressure in relation to spontaneously visible and recruitable collaterals. Circulation 75 (1987) 906-913
12. Ofili E., Kern M.J., Tatineni S., et al. Detection of coronary collateral flow by a Doppler-tipped guide wire during coronary angioplasty. Am Heart J 122 (1991) 221-225
13. Piek J.J., van Liebergen R.A., Koch K.T., Peters R.J., and David G.K. Comparison of collateral vascular responses in the donor and recipient coronary artery during transient coronary occlusion assessed by intracoronary blood flow velocity analysis in patients. J Am Coll Cardiol 29 (1997) 1528-1535
14. Seiler C., Fleisch M., Garachemani A., and Meier B. Coronary collateral quantitation in patients with coronary artery disease using intravascular flow velocity or pressure measurements. J Am Coll Cardiol 32 (1998) 1272-1279
15. Piek J.J., Koolen J.J., Metting van Rijn A.C., et al. Spectral analysis of flow velocity in the contralateral artery during coronary angioplasty: a new method for assessing collateral flow. J Am Coll Cardiol 21 (1993) 1574-1582
16. Pijls N.H., Bech G.J., el Gamal M.I., et al. Quantification of recruitable coronary collateral blood flow in conscious humans and its potential to predict future ischemic events. J Am Coll Cardiol 25 (1995) 1522-1528
17. Meier P., Gloekler S., Zbinden R., et al. Beneficial effect of recruitable collaterals: a 10-year follow-up study in patients with stable coronary artery disease undergoing quantitative collateral measurements. Circulation 116 (2007) 975-983
18. Pohl T., Seiler C., Billinger M., et al. Frequency distribution of collateral flow and factors influencing collateral channel development. Functional collateral channel measurement in 450 patients with coronary artery disease. J Am Coll Cardiol 38 (2001) 1872-1878
19. Wustmann K., Zbinden S., Windecker S., Meier B., and Seiler C. Is there functional collateral flow during vascular occlusion in angiographically normal coronary arteries?. Circulation 107 (2003) 2213-2220
20. Aarnoudse W., Van't Veer M., Pijls N.H., et al. Direct volumetric blood flow measurement in coronary arteries by thermodilution. J Am Coll Cardiol 50 (2007) 2294-2304
21. Piek J.J., van Liebergen R.A., Koch K.T., de Winter R.J., Peters R.J., and David G.K. Pharmacological modulation of the human collateral vascular resistance in acute and chronic coronary occlusion assessed by intracoronary blood flow velocity analysis in an angioplasty model. Circulation 96 (1997) 106-115
22. Seiler C., Fleisch M., Billinger M., and Meier B. Simultaneous intracoronary velocity- and pressure-derived assessment of adenosine-induced collateral hemodynamics in patients with one- to two-vessel coronary artery disease. J Am Coll Cardiol 34 (1999) 1985-1994
23. Seiler C., Fleisch M., and Meier B. Direct intracoronary evidence of collateral steal in humans. Circulation 96 (1997) 4261-4267
24. Werner G.S., Ferrari M., Betge S., Gastmann O., Richartz B.M., and Figulla H.R. Collateral function in chronic total coronary occlusions is related to regional myocardial function and duration of occlusion. Circulation 104 (2001) 2784-2790
25. Helisch A., Wagner S., Khan N., et al. Impact of mouse strain differences in innate hindlimb collateral vasculature. Arterioscler Thromb Vasc Biol 26 (2006) 520-526
26. Maxwell M.P., Hearse D.J., and Yellon D.M. Species variation in the coronary collateral circulation during regional myocardial ischaemia: a critical determinant of the rate of evolution and extent of myocardial infarction. Cardiovasc Res 21 (1987) 737-746
27. In: Schaper W., and Schaper J. (Eds). Collateral Circulation: Heart, Brain, Kidney, Limbs (1993), Kluwer Academic Publishers, Boston, MA
28. Schaper J., Konig R., Franz D., and Schaper W. The endothelial surface of growing coronary collateral arteries. Intimal margination and diapedesis of monocytes. A combined SEM and TEM study. Virchows Arch A Pathol Anat Histol 370 (1976) 193-205
29. Schaper W., De Brabander M., and Lewi P. DNA synthesis and mitoses in coronary collateral vessels of the dog. Circ Res 28 (1971) 671-679
30. Hoefer I.E., van Royen N., Buschmann I.R., Piek J.J., and Schaper W. Time course of arteriogenesis following femoral artery occlusion in the rabbit. Cardiovasc Res 49 (2001) 609-617
31. Schaper W., and Pasyk S. Influence of collateral flow on the ischemic tolerance of the heart following acute and subacute coronary occlusion. Circulation 53 (1976) 57-62
32. Garcia-Cardena G., Comander J., Anderson K.R., Blackman B.R., and Gimbrone Jr. M.A. Biomechanical activation of vascular endothelium as a determinant of its functional phenotype. Proc Natl Acad Sci U S A 98 (2001) 4478-4485
33. Scholz D., Ito W., Fleming I., et al. Ultrastructure and molecular histology of rabbit hind-limb collateral artery growth (arteriogenesis). Virchows Arch 436 (2000) 257-270
34. Heil M., Ziegelhoeffer T., Wagner S., et al. Collateral artery growth (arteriogenesis) after experimental arterial occlusion is impaired in mice lacking CC-chemokine receptor-2. Circ Res 94 (2004) 671-677
35. Voskuil M., Hoefer I.E., van Royen N., et al. Abnormal monocyte recruitment and collateral artery formation in monocyte chemoattractant protein-1 deficient mice. Vasc Med 9 (2004) 287-292
36. Heil M., Ziegelhoeffer T., Pipp F., et al. Blood monocyte concentration is critical for enhancement of collateral artery growth. Am J Physiol Heart Circ Physiol 283 (2002) 2411-2419
37. Eitenmuller I., Volger O., Kluge A., et al. The range of adaptation by collateral vessels after femoral artery occlusion. Circ Res 99 (2006) 656-662
38. Deindl E., Buschmann I., Hoefer I.E., et al. Role of ischemia and of hypoxia-inducible genes in arteriogenesis after femoral artery occlusion in the rabbit. Circ Res 89 (2001) 779-786
39. Schirmer S.H., van Royen N., Moerland P.D., et al. Local cytokine concentrations and oxygen pressure are related to maturation of the collateral circulation in humans. J Am Coll Cardiol 53 (2009) 2141-2147
40. Gray C., Packham I.M., Wurmser F., et al. Ischemia is not required for arteriogenesis in zebrafish embryos. Arterioscler Thromb Vasc Biol 27 (2007) 2135-2141
41. Seiler C., Pohl T., Wustmann K., et al. Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: a randomized, double-blind, placebo-controlled study. Circulation 104 (2001) 2012-2017
42. Buschmann I.R., Hoefer I.E., van Royen N., et al. GM-CSF: a strong arteriogenic factor acting by amplification of monocyte function. Atherosclerosis 159 (2001) 343-356
43. Zbinden S., Zbinden R., Meier P., Windecker S., and Seiler C. Safety and efficacy of subcutaneous-only granulocyte-macrophage colony-stimulating factor for collateral growth promotion in patients with coronary artery disease. J Am Coll Cardiol 46 (2005) 1636-1642
44. van Royen N., Schirmer S.H., Atasever B., et al. START trial: a pilot study on STimulation of ARTeriogenesis using subcutaneous application of granulocyte-macrophage colony-stimulating factor as a new treatment for peripheral vascular disease. Circulation 112 (2005) 1040-1046
45. Schumacher B., Pecher P., von Specht B.U., and Stegmann T. Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease. Circulation 97 (1998) 645-650
46. Baffour R., Berman J., Garb J.L., Rhee S.W., Kaufman J., and Friedmann P. Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: dose-response effect of basic fibroblast growth factor. J Vasc Surg 16 (1992) 181-191
47. Unger E.F., Banai S., Shou M., et al. Basic fibroblast growth factor enhances myocardial collateral flow in a canine model. Am J Physiol 266 (1994) 1588-1595
48. Laham R.J., Sellke F.W., Edelman E.R., et al. Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial. Circulation 100 (1999) 1865-1871
49. Simons M., Annex B.H., Laham R.J., et al. Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial. Circulation 105 (2002) 788-793
50. Rissanen T.T., Markkanen J.E., Arve K., et al. Fibroblast growth factor 4 induces vascular permeability, angiogenesis and arteriogenesis in a rabbit hindlimb ischemia model. FASEB J 17 (2003) 100-102
51. Grines C.L., Watkins M.W., Mahmarian J.J., et al. A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina. J Am Coll Cardiol 42 (2003) 1339-1347
52. Risau W. Mechanisms of angiogenesis. Nature 386 (1997) 671-674
53. Henry T.D., Annex B.H., McKendall G.R., et al. The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis. Circulation 107 (2003) 1359-1365
54. van Royen N., Voskuil M., Hoefer I., et al. CD44 regulates arteriogenesis in mice and is differentially expressed in patients with poor and good collateralization. Circulation 109 (2004) 1647-1652
55. Schirmer S.H., Fledderus J.O., Bot P.T., et al. Interferon-beta signaling is enhanced in patients with insufficient coronary collateral artery development and inhibits arteriogenesis in mice. Circ Res 102 (2008) 1286-1294
56. Meier P., Antonov J., Zbinden R., et al. Non-invasive gene-expression-based detection of well developed collateral function in individuals with and without coronary artery disease. Heart 95 (2009) 900-908
57. Chittenden T.W., Sherman J.A., Xiong F., et al. Transcriptional profiling in coronary artery disease: indications for novel markers of coronary collateralization. Circulation 114 (2006) 1811-1820
58. Simons M., Bonow R.O., Chronos N.A., et al. Clinical trials in coronary angiogenesis: issues, problems, consensus: an expert panel summary. Circulation 102 (2000) 73-86